HEOR News
Final Version of GLOBE Drug Payment Model Slashes Projected Savings (Healthcare Finance)
The Global Benchmark for Efficient Drug Pricing (GLOBE) Model, finalized by the US Centers for Medicare & Medicaid Services, will save Medicare beneficiaries an estimated $400 million over 7 years—far less than the $12 billion originally proposed. Read more.
Comments Open on Uncertainty-Related Methods in Health Economic Evaluations (HEMA)
Comments are open through November 2 on a draft report from the Health Economics Methods Advisory, focused on approaches for health technology assessment bodies to evaluate, present, and communicate uncertainty in health economic evaluations. Read more.
Experts Weigh in on US Food and Drug Administration’s Transparency Roadmap (Regulatory Focus)
The roadmap for FY2027 suggests the agency will initiate rules requiring public disclosure of submissions for new drug applications, biologics license applications, abbreviated new drug applications, and “related applications.” Read more.
German Claims Data Illustrate Consequences of Medicine Shortage Due to Recall (EJHE)
An analysis of claims data for more than 30,000 German patients found that the 2018 global recall of valsartan was associated with 5.3% higher costs for antihypertensives, along with increased general practitioner service utilization and care fragmentation. Read more.
US Government Launches $6 Million Real-World Evidence Innovation Challenge (NIH)
The US National Institutes of Health is launching the Real-World Evidence Innovation Challenge, a national prize competition designed to establish validated benchmarks for analytic methods operating on real-world clinical data. Up to $6 million in prizes will be awarded. Read more.
London’s Clean Air Zone Initiative Associated With Better Lung Function in Children (Lancet)
Introduction of the Ultra Low Emission Zone in London was associated with improved lung function growth trajectories in children there, compared with children in a comparator site, suggesting the public health initiative helped restore previous deficits in lung development. Read more.
Study Finds Cancer Screening Rate Disparities Affecting Adults With Disabilities (American Cancer Society)
An American Cancer Society study found that adults with disabilities in the United States have lower rates of breast, cervical, and colorectal cancer screening than people with no disability-related difficulties. At-home stool testing rates, however, were similar. Read more.
Expanding Percutaneous Coronary Intervention Access Improves Outcomes (JAMA Network Open)
In a study of nearly 600,000 patients with acute myocardial infarction, expanded access to percutaneous coronary intervention was associated with improved outcomes in previously underserved communities but had limited benefit in areas already being served. Read more.
Mortality Data Favor Private Settings for Acute Lymphoblastic Leukemia Care (Lancet Regional Health – Americas)
In a study of more than 1100 patients treated for acute lymphoblastic leukemia in Brazil, Argentina, or Chile, mortality risk was significantly lower for people treated at private institutions than those treated at public institutions. Read more.
Human Papillomavirus Vaccine May Lower Risk of Adverse Pregnancy Outcomes (BMJ)
Swedish researchers found that quadrivalent human papillomavirus vaccination before pregnancy was associated with a lower risk of adverse pregnancy outcomes, extending benefits of human papillomavirus vaccination beyond cancer prevention. Read more.
African Leaders Commit to AI-Assisted Preparedness for Health Emergencies (WHO)
African leaders and global health representatives have adopted a call to action that calls for stronger cross-border collaboration and the responsible use of artificial intelligence to strengthen preparedness for public health emergencies caused by infectious diseases. Read more.
European Parliament Backs Stronger, Prevention-Focused Cardiovascular Strategy (Eureporter)
Members of the European Parliament overwhelmingly voted to support a new EU cardiovascular diseases strategy that prioritizes prevention, emphasizing risk factors involving alcohol, food, and tobacco and nicotine products. Read more.
